You are here

Article Text

Article menu
Download PDFPDF
PostScript
Correspondence
Neural cell adhesion molecule (CD56)-positive B cell lymphoma of the urinary bladder
  1. Tomonori Kawasaki1,
  2. Masamichi Suzuki1,
  3. Ayaka Sato1,
  4. Akiko Yashima-Abo2,
  5. Takashi Satoh2,
  6. Renpei Kato3,
  7. Yoichiro Kato3,
  8. Wataru Obara3,
  9. Tadashi Shimoyama4,
  10. Yoji Ishida4,
  11. Tamotsu Sugai1
  1. 1 Department of Molecular Diagnostic Pathology, Iwate Medical University School of Medicine, Morioka, Japan
  2. 2 Department of Pathology, Iwate Medical University School of Medicine, Morioka, Japan
  3. 3 Department of Urology, Iwate Medical University School of Medicine, Morioka, Japan
  4. 4 Department of Hematology and Oncology, Iwate Medical University School of Medicine, Morioka, Japan
  1. Correspondence to Dr Tomonori Kawasaki, Department of Molecular Diagnostic Pathology, Iwate Medical University School of Medicine, 19-1 Uchimaru, Morioka, Iwate 020-8505, Japan; tomonori{at}yamanashi.ac.jp

https://doi.org/10.1136/jclinpath-2015-203250

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    CD56, the neural cell adhesion molecule (NCAM), is a member of the immunoglobulin superfamily and is associated with cell-to-cell adhesion and migration.1 Among haematological malignancies, CD56 expression has been described mainly in NK/T cell lymphoma, plasma cell myeloma and acute myeloid leukaemia, and rarely in B cell lymphomas, accounting for no more than 0.5% of all B lymphomas.2–8 Malignant lymphoma constitutes <1% of bladder neoplasms and low-grade mucosa-associated lymphoid tissue (MALT) type is most frequent.9 Herein, we describe the first case of primary CD56-positive B cell lymphoma (diffuse large B cell lymphoma, DLBCL) of the urinary system.

    The patient, a 60-year-old Japanese woman, presented with recurrent cystitis. Cystoscopy revealed a mass lesion in the urinary bladder. On MRI, this lesion appeared as a sessile tumour protruding into the bladder lumen at the posterior wall, with destruction of the muscularis propria. These images suggested an invasive urothelial carcinoma. Systemic CT, especially of lymph nodes, detected no other suspicious lesions. We performed transurethral biopsy of the bladder tumour after obtaining informed consent.

    Histologically, medium to large neoplastic cells with high nuclear/cytoplasmic ratios showed diffuse and/or relatively cohesive proliferations (figure 1A, B). Centrally located, ovoid or irregular-shaped nuclei had a finely dispersed chromatin pattern, occasionally with prominent nucleoli (centroblastic variant). Mitotic figures were numerous (98 per 10 high-power fields). …

    View Full Text

    Footnotes

    • Contributors TK, MS, AS, AA and TS histopathologically analysed the case and interpreted the results. RK, YK and TS gathered the clinical data and follow-up information. TK, MS and AS drafted the manuscript and conducted the literature search. AA, TS, WO, YI and TS reviewed the manuscript.

    • Funding This work was supported by a Grant-in-Aid for Scientific Research (No. 25460414) from the Japanese Ministry of Education, Culture, Sports, Science and Technology.

    • Competing interests None declared.

    • Patient consent Obtained.

    • Ethics approval This study was conducted with the approval of the ethics committee, Iwate Medical University School of Medicine.

    • Provenance and peer review Not commissioned; externally peer reviewed.